Prion Diseases: Biomarkers

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion proteins, as an important biomarker of prion disease, are responsible for the transmissible spongiform encephalopathies. Here is the latest research investigating biomarkers in prion diseases.

May 17, 2020
Review
Open Access

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy

International Journal of Molecular Sciences
Laura GattiAnna Bersano
April 19, 2020
Open Access

The cellular prion protein is a stress protein secreted by renal tubular cells and a urinary marker of kidney injury

Cell Death & Disease
Yohan BignonNicolas Pallet
April 5, 2020
Review
Open Access

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines

International Journal of Molecular Sciences
Masaru TanakaLászló Vécsei
May 23, 2020
Open Access

Characterization of Sporadic Creutzfeldt-Jakob Disease and History of Neurosurgery to Identify Potential Iatrogenic Cases

Emerging Infectious Diseases
Tsuyoshi HamaguchiMasahito Yamada
February 29, 2020

Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients

Neuroscience Letters
Bing LengZhenguang Li
March 12, 2020
Open Access

TeaMiD: a comprehensive database of simple sequence repeat markers of tea

Database : the Journal of Biological Databases and Curation
Himanshu DubeyTapan Kumar Mondal
March 22, 2020
Review

Towards a treatment for genetic prion disease: trials and biomarkers

Lancet Neurology
Sonia M VallabhEric S Lander
January 17, 2020

Evaluation of rat major celluler prion protein for early diagnosis in experimental rat brain trauma model

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES
Alev KuralSezgin Sarıkaya
July 29, 2020
Preprint
Open Access

Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases

MedRxiv : the Preprint Server for Health Sciences
A. ThompsonSimon Mead
June 19, 2020
Open Access

MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

Biomolecules
Janne Markus ToivonenInmaculada Martín-Burriel
May 12, 2020

Proteomics in Neurodegenerative Disease

Current Protein & Peptide Science
Nidhi PuranikJun-O Jin
February 29, 2020
Review

Preclinical biomarkers of prion infection and neurodegeneration

Current Opinion in Neurobiology
Tze How Mok, Simon Mead
May 23, 2020
Open Access

Disease-Specific Changes in Reelin Protein and mRNA in Neurodegenerative Diseases

Cells
Laia LidónJose Antonio Del Rio
July 29, 2020
Review

Proteopathic Seed Amplification Assays for Neurodegenerative Disorders

Clinics in Laboratory Medicine
Natália do Carmo Ferreira, Byron Caughey
August 2, 2020

The Yarrowia lipolytica orthologs of Sup35p assemble into thioflavin T-negative amyloid fibrils

Biochemical and Biophysical Research Communications
Mehdi Kabani, Ronald Melki

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/prion-diseases-biomarkers/25e9ff96-ff07-46ae-a7b9-622bd99c5314